Publication contributions from Translational Ear Physiology Lab
- Kumar, P. N., Vlajkovic, S. M., Thorne, P. R., & Suzuki-Kerr, H. (2026). Expression of the P2X1 receptor remains in the type II spiral ganglion neurons in the mature rat cochlea. Purinergic Signalling, 22(1), 14. DOI: 10.1007/s11302-026-10129-7. PMID: 41579306. PMCID: PMC12831720.
- Fisher-Ridoux, A., & Suzuki-Kerr, H. (2026). P2X4 receptors as the dynamic regulators of auditory sensory cell activity: a potential new mechanism for protecting hearing?. Purinergic Signalling, 22(1), 12. DOI: 10.1007/s11302-026-10130-0. PMID: 41572111. PMCID: PMC12827844.
- Huang ZS, Ross JM, Lin SCY, Kumar PN, Roy K, Vlajkovic SM, Thorne PR, Suzuki-Kerr H. (2025). Subcellular localization of the P2X4 receptor in sensory hair cells of Wistar rat cochlea. Histochemistry and Cell Biology. 163:54. DOI: 10.1007/s00418-025-02386-1. PMID: 40392390. PMCID: PMC12092529.
- Vlajkovic, S. M., Suzuki-Kerr, H., & Nayagam, B. A. (2025). Cochlear Homeostasis in Sensorineural Hearing Loss: Mechanisms, Implications, and Therapeutic Prospects. International Journal of Molecular Sciences, 27(1), 102. DOI: 10.3390/ijms27010102. PMID: 41515981. PMCID: PMC12786260.
- Suzuki-Kerr H*, Leung JH*, Hector Z*, Manuel AR*, Bergin M, Burton-Harris L, Choi G, McLaren R, Pokorny MA, Singh A, Taylor R, Thomson BJ, Holt EAL. (2025). Perspectives of early career hearing and vestibular researchers in Aotearoa New Zealand. Journal of the Royal Society of New Zealand. 55(3):754–759. DOI: 10.1080/03036758.2024.2384458 *Shared first authorship.
- Lue P-Y, Suzuki-Kerr H. (2024). Pathophysiology of genetic hearing loss. The Journal of Physiology. DOI: 10.1113/JP286697. Journal Club article.
- Lue, P. Y., Oliver, M. H., Neeff, M., Thorne, P. R., & Suzuki-Kerr, H. (2023). Sheep as a large animal model for hearing research: comparison to common laboratory animals and humans. Laboratory Animal Research, 39(1), 31. DOI: 10.1186/s42826-023-00182-3.
- Suzuki-Kerr,
H. (2023). ATP released from dying cancer cells stimulates P2X4
receptors and mTOR in their neighbours. Purinergic Signalling, 1-4. DOI:
10.1007/s11302-023-09926-1. Journal Club
- Han S, Suzuki-Kerr H, Vlajkovic SM, Thorne PR. The developmental journey of therapies targeting purine receptors: from basic science to clinical trials. (2022)Review Article. Purinergic Signalling. Sept issue; 1-16. DOI: 10.1007/s11302-022-09896-w